US AIDS Group Hails Brazil for Breaking Merck’s AIDS Drug Patent

Brazil produces some of its own AIDS drugs AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention hailed the news that the President of Brazil, Luiz Inácio Lula da Silva, signed today a compulsory license for Merck's HIV/AIDS drug Efavirenz, freeing the country to buy a generic formula of the medication or produce it in its all state laboratories.

AHF also operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia. For them, Lula's move is seen as a victory for global AIDS activism and AIDS patients worldwide.

President Lula de Silva's decision comes after reports of a breakdown in negotiations between Brazil and the New Jersey based drug giant Merck. According to the country's health ministry, Brazil had asked Merck to cut the price of Efavirenz to 65 cents a pill from $1.57 and Merck had refused.

Brazil's decision to issue a compulsory license for the drug, which will allow the country to manufacture the drug or to buy generic versions, comes on the heels of Thailand's recent move to issue a compulsory license for Abbott's AIDS drug, Kaletra and in the lead-up to an AIDS Healthcare Foundation-hosted discussion regarding AIDS drug-pricing for Mexico, scheduled for June 4th in Mexico City.

"In announcing its intention to issue a compulsory license for Merck's AIDS drug Efavirenz, Brazil is once again leading the way to affordable AIDS drug access for every nation," added Michael Weinstein, President of AIDS Healthcare Foundation.

"We salute the courage of countries such as Brazil, Thailand and Mexico who are fighting to ensure drug access for AIDS patients the world over. Today is a victory for AIDS activists and patients everywhere, and proof that drug companies will go down in defeat every time they place themselves in the way of justice for AIDS patients."

Flexibilities under the World Trade Organization's (WTO) Trade-related Aspects of Intellectual Property Rights (TRIPS) Agreement allow governments to issue compulsory licenses (including royalty payment to the patent owner) if the country deems it necessary and appropriate to protect the health of its citizens.

Brazil has been widely praised by global AIDS treatment activists for its government AIDS program, which provides free medication for anyone who needs it.

In the Latin American region, AIDS Healthcare Foundation operates free HIV/AIDS treatment clinics in Guatemala (Quetzaltenango) and in Mexico (Tijuana and Puerto Vallarta).

Tags:

You May Also Like

Brazil Reaffirms It Will Give US$ 1 Million to Rebuild Lebanon

Celso Amorim, Brazil's Minister of Foreign Relations confirmed during the International Conference for Lebanon ...

American A&E and Brazil’s Millefios Join Forces

U.S.-based Ruddick Corporation announced today that its subsidiary, American & Efird, Inc. (A&E), has ...

With High Inflation and Low Growth Brazil Doesn’t Know What to Do With Its Interest Rate

Brazilian analysts believe Brazil’s central bank will leave its benchmark interest rate unchanged at ...

Looking for Love, Enlightenment and Justice in the Land of Brazil – Chapter I

I had a love so strong that nothing else mattered. Carissia was more important ...

Brazilian Orange Juice Sales to US Jump with a Little Help from Hurricane Wilma

Brazilian orange juice exports may grow as much as 50% this year, thanks to ...

US Trouble Slows Down Brazil’s Embraer

Embraer, the Brazilian Airplane Manufacturer Company, reduced its forecast of aeroplane deliveries from 160 ...

Brazil’s Joint Mission of Government and Entrepreneurs to Visit Countries That Banned Beef

The Brazilian government and private enterprise decided to put together joint missions to visit ...

Rogues Gallery – Brazil’s PMDB Comes “Clean” at Last

When I first started to cover the Brazilian political scene in the mid-90s I ...

The Frying of a Black Minister in Brazil

What the Lula administration wants is Minister Benedita da Silva’s seat, but they avoid ...

Brazil Keeps Key Interest Rates for Third Month at 19.75%

Brazil’s Monetary Policy Committee (Copom) decided, unanimously, for the third straight month, to maintain ...